APA (7th ed.) Citation

Jr, R. J., EB, F., F, A., LC, P., LSF, A., CN, K., & E, D. (2018). Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease. Transplant infectious disease : an official journal of the Transplantation Society, 20(5), e12929. https://doi.org/10.1111/tid.12929

Chicago Style (17th ed.) Citation

Jr, Reusing JO, Feitosa EB, Agena F, Pierrotti LC, Azevedo LSF, Kotton CN, and David-Neto E. "Cytomegalovirus Prophylaxis in Seropositive Renal Transplant Recipients Receiving Thymoglobulin Induction Therapy: Outcome and Risk Factors for Late CMV Disease." Transplant Infectious Disease : An Official Journal of the Transplantation Society 20, no. 5 (2018): e12929. https://doi.org/10.1111/tid.12929.

MLA (9th ed.) Citation

Jr, Reusing JO, et al. "Cytomegalovirus Prophylaxis in Seropositive Renal Transplant Recipients Receiving Thymoglobulin Induction Therapy: Outcome and Risk Factors for Late CMV Disease." Transplant Infectious Disease : An Official Journal of the Transplantation Society, vol. 20, no. 5, 2018, p. e12929, https://doi.org/10.1111/tid.12929.